Webinar Objectives: 

• Outlining some of the current Iron and PBM activities being used in the UK
• Highlighting differences in practice when managing paediatrics & adults

Speakers: Dr Paolo Polzella and Dr Anne Kelly

Webinar Objectives: 

•  Implementation of goal-directed bleeding management:
  • Coagulation changes during bleeding
  • What is goal directed bleeding management
  • Why bring in viscoelastic testing
  • How do you introduce it
  • Is it effective – impact on blood product usage

Speakers: Kate Maynard, Dr Sam Hird, Dr Amrit Dhadda and Prof Rachel Collis

Objetivos del seminario web:

• Se discutira y revisara como resolver casos complejos e intermedios de aloanticuerpos contra células rojas y plaquetas usando serologia y metodos moleculares,
• interferencia de tratamientos monoclonales en immunohematologia ,
• donantes raros y poco comunes

Oradora:  Nancy Benitez;  Claribel Resto; MHSc, MT (ASCP) SBB CM   Baldomero Castro, MD   Lynsi Rahorst, MHPE, MLS(ASCP)SBB Dr.Fernando Martinez, MD, MScP; Section Head and Medical Director Anderson Cancer Center.   Dr. Hector Baptista MD   Marisela Marchan, MSTM , MT (ASCP)SBB

Obiettivi el corso:

• Getione delle liste di lavoro
• Gestione dei risultati
• Gestione dei report
• Modulo Panel ID
• Gestione degli archivi

Oratore: Gianni Giuffrè

Obiettivi del webinar:

• Trasfusioni di globuli rossi nei neonati
• Trasfusioni di piastrine nei neonati

Oratore: Martha Sola-Visner. MD.

Obiettivi del webinar:
• Definire risultati di laboratorio di coagulazione normali e anormali.
• Correlare i risultati di laboratorio con segni e sintomi clinici comuni nel paziente.
• Discriminare i risultati di laboratorio delle piastrine normali e anormali.
• Applicare i risultati della coagulazione e dell'ematologia in esempi di casi di studio incentrati sulla gestione di trasfusioni di emoderivati appropriate o interventi medici.

Oratore: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Objetivos do seminário web:

• Isohemaglutininas e a Transfusao de Plaquetas
• validação do crossmatch plaquetario por fase sólida para manejo da Refratariedade Plaquetaria.
• inovações para a identificaçao de anticorpos de especificidade não determinada e as técnicas moleculares na determinação de alelos de grupos.

Orador: Jayanna Slayten, MS, MT(ASCP)SBBCM

Objectif du webinaire:
• Définir les résultats normaux et anormaux du laboratoire de coagulation.
• Corréler les résultats de laboratoire avec les signes et symptômes cliniques courants chez le patient.
• Distinguer les résultats normaux et anormaux du laboratoire de plaquettes.
• Appliquer les résultats de la coagulation et de l'hématologie dans des exemples d'études de cas sur la provision de transfusion appropriée de produits sanguins ou d'une intervention médicale.

Orateur: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Objectif du webinaire:

• Gestion des listes de travail
• Fgestion des résultats
• Gestion des rapports
• Module Panel ID
• Gestion des archives

Orateur: Gianni Giuffrè

Webinar Objective:

• LEARNing is fun in a new way when you complete this virtual intensive, transfusion medicine investigation.

Zielsetzung des Webinars:

Dieses Seminar richtet sich an Transfusionsmediziner, Transfusionslaborteams und Transfusionsberater, die die Bedürfnisse dieser speziellen Patientengruppe -den Neugeborenen- besser verstehen möchten.

Referentin: Martha Sola-Visner. MD.

Objetivos del seminario web:

Este seminario está dirigido a profesionales de transfusión, equipos de laboratorio de transfusión y consultores de transfusión con ánimo de comprender mejor las necesidades de este grupo especial de pacientes, los recién nacidos.

Oradora: Martha Sola-Visner. MD.

Webinar-Ziele:
• Normale und abnormale Ergebnisse des Gerinnungslabors definieren.
• Korrelation der Laborergebnisse mit häufigen klinischen Anzeichen und Symptomen des Patienten.
• Normale und abnormale Thrombozyten-Laborergebnisse unterscheiden.
• Anwendung von Gerinnungs- und Hämatologieergebnissen in Fallstudienbeispielen mit Fokus auf die Bereitstellung einer geeigneten Transfusion von Blutprodukten oder medizinischen Maßnahmen.

Zusammenfassung der Sitzung:
Die Fähigkeit zur Aufrechterhaltung der Hämostase wird im Labor mit Gerinnungs- und Hämatologiemethoden überwacht. In diesem Kurs werden die Labormethoden und Analysen definiert, die bei der Bewertung der Hämostase eines Patienten eingesetzt werden. Es wird erörtert, wie eine normale Hämostase aufrechterhalten wird und welche Maßnahmen bei abnormalen hämostatischen Befunden ergriffen werden können. Die Blutbank oder der Transfusionsdienst helfen bei der Versorgung von Patienten mit abnormalen Hämostase- oder Thrombozytenbefunden durch die rechtzeitige Bereitstellung entsprechender Blutkonserven.

Vortragende: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Objetivos del seminario web:

• Definir resultados de laboratorio de coagulación normales y anormales.
• Correlacionar resultados de laboratorio con signos y síntomas clínicos comunes en el paciente.
• Discriminar resultados de laboratorio de plaquetas normales y anormales.
• Aplicar resultados de coagulación y hematología en estudios de casos centrándose en la provisión de transfusión de hemoderivados o intervención médica.

Oradora: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Lassen Sie uns eine kurze Reise machen durch die Themen

• Arbeitslisten-Management
• Ergebnis-Management
• Bericht-Management
• Panel ID | Module
• Archivierung

Seien Sie gespannt, im Bereich des Datenmanagements geschehen aufregende Dinge!

Objetivos del seminario web:

• Gestión de listas de trabajo
• Gestión de resultados
• Gestión de informes
• Panel de identificación | Módulo
• Gestión de archivos

Oradora: Gianni Giuffrè

Objetivos del seminario web:

•  el desarrollo de la inmunohematología hasta los avances tecnológicos e investigació
• "genómica" y descubrimiento continuo de grupos sanguíneos

Oradora: Dr. Lilian Castilho

Webinar Objectives:

• Worklist Management
• Results Management
• Report Management
• Panel ID | Module
• Archive Management

Speaker:  Gianni Giuffrè

Webinar Objectives:

This seminar is aimed at Transfusion Practitioners, Transfusion Laboratory Teams and Transfusion Consultants keen to better understand the needs of this special patient group, neonates.

Speaker: Martha Sola-Visner. MD.

Webinar Objectives:
• Organize and categorize transfusion complications given the reported signs and symptoms.
• Discover how laboratory findings correlate with the clinical signs and symptoms of transfusion complications.
• Compare and contrast acute and delayed transfusion reactions.
• Apply how to define the adverse complications of transfusion in example case studies.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Distinguish immune response into the action of T Cells and B Cells.
• Recognize the role of immunoglobulins and cells involved in primary and secondary immune response.
• Outline function and process of complement activation in transfusion medicine.
• Demonstrate genetic concepts of blood groups exploring pedigree analysis and population genetics.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Identify the common blood groups by genetic background, antigen, antibody and clinical significance.
• Discriminate uncommon blood groups by genetic background, antigen, antibody and clinical significance.
• Give examples of unique characteristics of blood groups and how they relate to the clinical outcomes in patients.
• Apply the knowledge of blood groups to provide the most appropriate blood products for transfusion.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Appraise the value of common serologic blood bank methods for the resolution
of serologic blood bank challenges.
• Categorize the methods and tools for atypical serum/plasma challenges compared to red cells challenges.
• Define a systematic approach for ABO discrepancies and atypical antibody detection findings.
• Employ serologic methods in case study examples to demonstrate efficient application.

Speaker:  Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Define normal and abnormal coagulation lab findings.
• Correlate laboratory results with common clinical signs and symptoms in the patient.
• Discriminate normal and abnormal platelet laboratory results.
• Apply coagulation and hematology results in case study examples focusing on the provision of appropriate
transfusion of blood products or medical intervention.

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Webinar Objectives:
• Explain detection and identification of red cell alloantibodies.
• Explore problem solving techniques including evaluation of the patient’s clinical and transfusion history, autocontrol, DAT and red cell phenotype.
• Define appropriate testing methods for IgM compared to IgG reactive antibodies.
• Apply antibody identification practices in case studies

Speaker: Jayanna Slayten, MS, MT(ASCP)SBB^CM

Objetivos do seminário web:

• validação e conduta nas transfusões de plaquetas
• Crossmatching plaquetário
• Refratariedade Plaquetária.

Speakers: Ana Paula Rocha Diniz Zanelli; Cristina Altobeli; Juliana Pires Marafon Franz

Objetivos do seminário web:

• Reagentes Especiais em Imunohematologia: como usar e qual a importância na resolução de casos clínicos complexos
• A importância da detecção sorológica para direcionar a investigação molecular
• Tipagem molecular dos genes de grupos sanguíneos no auxílio diagnostico.

Speakers: Regina Cardoso; Tatiane de Paula Vendrame; Carine Arnoni, Tamires Delfino dos Santos, Lilian Castilho, PhD

Webinar Objectives:

•  Advances in treatments for patients with Sickle Cell Disease
•  National Haemoglobinopathy Registry

Speakers: Noemi Roy, Farrukh Shah

Webinar Objectives: 

• Prevalence of red cell antigens
• Prevalence of alloantibodies
• Role of Prophylactic antigen matched blood in Thalassemia, Sickle Cell disease, AIHA, women in childbearing age, Chronic Renal failure
• Cost effectiveness

Speaker: Dr. Rajeshwari Basavanna

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced. Click 'LAUNCH COURSE' below to submit results for Self-check II Competency Kit.

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced.  Click 'LAUNCH COURSE' below to submit results for RiSE Competency Kit.

Webinar Objectives: 

• Immucor is committed to supporting the testing you perform by offering a complete and convenient line of competency testing products – from basic to advanced.  Click 'LAUNCH COURSE' below to submit results for Gamma® Tech-Chek Competency Kit.

Webinar Objectives:

• Blood component usage in the pre hospital setting
• The use of O positive red cells in the pre hospital setting

Speaker: Dr. James Raitt MBChB, FRCEM, FIMC, Kerry Dowling

Webinar Objectives: 

• RhD Case Studies: Interpretation and Patient Risks in Transfusions
• Management of platelet alloimmunization on the Maternity Laboratory
• The challenging effects of monoclonal antibody therapies on the Transfusion Laboratory

Speakers: Dr Lilian Castilho, PhD, Dr Rachel Petermann, MD, PhD, Julie Staves Manager, Transfusion Laboratory

Webinar Objectives: 

• A new front in myeloma therapy and an emerging complication in blood bank testing

Speaker: Dr. Rasika Setia

Webinar Objectives: 

• A breakthrough in ABO isoagglutinin titration automation: reason to believe & its benefits

Speakers: Dr. Soma Agrawal

Webinar Objectives: 

• Methods to obtain access to CCP
• NYC & the Covid-19 Pandemic
• CUIMC CCP Clinical Trials
• Impacts on Transfusion Service operations

Speakers: Joseph (Yossi) Schwarts

Webinar Objectives: 

• Seeing antibody detection through the lense of Sherlock Holmes

Speaker: Dawn M. Rumsey

Webinar Objectives: 

• Review platelet refractoriness and fetal neonatal alloimmune thrombocytopenia
• Describe how serologic testing can aid clinical management and selection of blood products
• Describe how HPA genotyping can be helpful in different diagnosis of FNAIT
• Describe how platelet donors are screened to identify how whose platelet products may be useful for HPA aluminized patients
• Use cases to illustrate these points

Speaker: Margaret A. Keller, PhD

Webinar Objectives: 

• Serological weak D phenotypes to RHD genotyping: How will I know?

Speaker: Susan T. Johnson 

Webinar Objectives: 

• Pathophysiology of thrombotic thrombocytopenic purpura (TTP)
• Laboratory characteristics of various ADAMTS13 tests
• Clinical applications of ADAMTS13 testing in diagnostics and management of patients with TTP

Speaker: Dong Chen MD PhD

Webinar Objectives:

• Describe the relationship between Ren Blood cell antigens and their corresponding antibodies
• Learn about genes, antigens, and antibodies and how they are arranged in each system

Speaker: N/A

Webinar Objectives: 

• Review the Serologic Presentation
•  Discuss Adsorption Procedures
• How to differentiate WAIHA from Drug-Induced Hemolytic

Speaker: Sue Johnson MSTM, MT(ASCP)SBB

Objetivos del seminario web: 

• Definición Antígenos de Baja Frequencia (ABF)
• ¿Porqué estudiar los anticuerpos contra ABF?
• Dificultades en el estudio de ABF

Oradora: Dra. María Antonieta Nuñez

Webinar Objectives: 

• Discuss antibody development as part of the immune system
• Compare and contrast IgM and IgG class antibodies
• Examine reactivity of IgM and IgG class antibodies in common antibody detection methodologies
• Review publications on clinical significance of IgM and IgG class antibodies

Speaker: Tricia Sanders

Webinar Objectives: 

• Review Chronic Transfusion Therapy (CTT) for Sickle Cell Anemia (SCA)
• Present a prospective study of RBC genotyping of SCA patients and transfused units during CTT
• Clinical applications

Speaker: Marianne E. McPherson Yee, MD

Webinar Objectives: 

• Walk though case studies related to Immunohematology

Speaker: Rebacca Coward, MT (ASCP) SBB^CM

Webinar Objectives: 

• Geneotyping to resolve e-like Antibodies

Speaker: Dr. Shaun Lawicki, MBBS

Webinar Objectives: 

• Recognize serological testing results associated with monoclonal antibody therapy
• Identify when a patient is being treated with monoclonal antibody therapy based on what other drugs the patient is currently on
• Recognize monoclonal antibody therapy drugs that can interfere with serological testing

Speaker: Cynthia Ngo MLS (ASCP)^CM SBB^CM

Webinar Objectives: 

• The Challenging Effects of monoclonal anti-CD47 on the Transfusion Laboratory

Speaker: Julie Staves